This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Sarepta Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Lilly East - Innovator in Muscular Dystrophy Treatment
Introduction
Lilly East is a prominent inventor based in Cambridge, MA (US), known for her groundbreaking work in the field of muscular dystrophy treatment. With a focus on innovative dosing regimens, she has made significant contributions to the medical community, particularly for patients suffering from Duchenne muscular dystrophy (DMD).
Latest Patents
Lilly East holds 1 patent that details treatment methods for muscular dystrophy. Her patent describes new dosing regimens for treating DMD using an antisense oligonucleotide conjugate that facilitates the skipping of an exon in the human dystrophin gene. Additionally, the patent outlines a method for treating patients with an antisense oligomer CPP conjugate combined with a magnesium supplement.
Career Highlights
Throughout her career, Lilly has worked with notable companies such as Sarepta Therapeutics, Inc. and Biogen MA Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to advancements in muscular dystrophy treatments.
Collaborations
Lilly has collaborated with esteemed colleagues, including Huadong Sun and Jon Tinsley, to further her research and development efforts in the treatment of muscular dystrophy.
Conclusion
Lilly East's innovative work in the treatment of muscular dystrophy showcases her dedication to improving patient outcomes. Her contributions to the field are invaluable and continue to inspire future advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile